Jennifer Han, MD, MSCE

Dr. Han graduated from Northwestern University Feinberg School of Medicine.  She completed her residency at NewYork-Presbyterian/Columbia University Medical Center and her fellowship at the University of Pennsylvania.  Her clinical interests focus on treatment of infections due to multidrug-resistant organisms, including those due to methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE).  Her research focuses on healthcare-associated infections, antibiotic resistance, and antibiotic use, with a focus on infections due to multidrug-resistant organisms across inter-related healthcare settings (e.g., post-acute care).


Geeta Sood, M.D.

Geeta Sood, M.D. is an Assistant Professor of Medicine at Johns Hopkins University and Hospital Epidemiologist at Johns Hopkins Bayview Medical center. She completed her medical training, residency in internal medicine and fellowship training in infectious diseases at Temple University Medical School. She has been the Hospital Epidemiologist at Johns Hopkins Bayview Medical Center since 2011 where she led several successful process improvement interventions particularly in the burn intensive care unit for which she won the Armstrong Clinical Excellence Award in Patient Safety in 2015. She is a member of the Maryland Healthcare Associated Infections Advisory Board and teaches the Healthcare Epidemiology course at the Bloomberg School of Public Health. Her research interests are in the role of the microbiome in preventing healthcare associated infections and burn infections.


Sharon Brodie Wright, MD, MPH

Dr. Wright is an Associate Professor of Medicine at Harvard Medical School and Director, Infection Control/ Hospital Epidemiology. Her clinical expertise is in the areas of Infectious Disease, Epidemiology, Antibiotics, Nosocomial Infection, MRSA, and Infection Control. She received her MD from Columbia University College of Physicians and Surgeons and completed and Infectious Disease Fellowship at Brigham & Women’s Hospital.


Louis B. Rice, MD

Louis B. Rice, MD is the Chairman of the Department of Medicine, Joukowsky Family Professor of Medicine, and Professor of Molecular Microbiology & Immunology at the Warren Alpert Medical School of Brown University, and the Physician-in-Chief of Medicine at Rhode Island Hospital and The Miriam Hospital in Providence, RI. He serves as the Executive Physician-in-Chief of Medicine at Memorial Hospital of Rhode Island, the Providence Veterans Administration Medical Center and Women & Infants Hospital. Dr. Rice is also the President and Chief Executive Officer of University Medicine, Inc. Dr. Rice is a member of the American Society for Microbiology (ASM) and Editor-in-Chief of the ASM journal, Antimicrobial Agents and Chemotherapy; the Infectious Disease Society of America, where he currently is on the Board of Directors, chairs the research committee and the research on resistance working group; and is a fellow of the American College of Physicians. Dr. Rice received his undergraduate degree from Harvard University and his medical degree from Columbia University College of Physicians and Surgeons. He completed his internship and residency in medicine at New York University Medical Center. He also completed clinical and research fellowships in infectious diseases at the former New England Deaconess Medical Center and Harvard Medical School.


Angela Caliendo, MD, PhD

Angela M. Caliendo, MD, PhD is Professor, Executive Vice Chair of the Department of Medicine, and Director of the Division of General Internal Medicine at the Warren Alpert Medical School of Brown University. She also serves as the Vice President of University Medicine, Inc. Dr. Caliendo received a PhD (Biochemistry) and MD from Case Western Reserve University School of Medicine and completed an internship and residency in Internal Medicine at Brigham and Women’s Hospital in Boston, MA and an Infectious Diseases fellowship at Massachusetts General Hospital, Boston MA. After completing fellowship training she joined the faculty at the MGH as an assistant director of microbiology with responsibilities for the clinical virology and molecular diagnostics sections of the laboratory. In 1999 she joined the faculty at Emory University School of Medicine, initially as the Medical Director of the Microbiology and Molecular Diagnostics Laboratories and later became the Director of Emory Medical Laboratories, and Professor and Vice Chair of Pathology and Laboratory Medicine.


Anthony D. Harris

Dr. Harris is an infectious disease physician and epidemiologist whose research interests include emerging pathogens, antimicrobial-resistant bacteria, hospital epidemiology/infection control, epidemiologic methods in infectious diseases and medical informatics. He has published over 160 papers. He has current or has had funding from the NIH, CDC and AHRQ to study antibiotic resistance and hospital epidemiology.


Sarah Haessler, MD

Dr. Haessler is the Hospital Epidemiologist and a faculty member in the division of Infectious Diseases at Baystate Medical Center in Springfield Massachusetts, and an Assistant Professor of Medicine at Tufts University School of Medicine. In addition, she oversees infection control at 5 community hospitals in the Western Massachusetts region. She received her medical degree at the George Washington University School of Medicine and completed her medicine and infectious diseases fellowship training at Dartmouth Hitchcock Medical Center. Dr. Haessler’s interests are in the utilization of large datasets to assess real world practice and outcomes of nosocomial infections, and in the development of infection control networks to improve collaboration between facilities on a regional level.


Michael Klompas, MD

Dr. Klompas works on enhancing public health surveillance using electronic health information in two major spheres: hospital-level surveillance for nosocomial complications and population-level surveillance for infectious diseases and chronic conditions. Dr. Klompas’ hospital level surveillance work is primarily supported by the Centers for Disease Control and Prevention. Under the auspices of the CDC Epicenters he has worked on developing objective, automatable definitions for complications of mechanical ventilation. This work ultimately led to CDC replacing their longstanding definition for ventilator-associated pneumonia with definitions for “ventilator-associated events.”

Kim Chapin, MD, MA

Dr. Chapin is Professor of Pathology and Laboratory Medicine and of Medicine at The Alpert Medical School, Brown University and is the Director of Microbiology for Lifespan Academic Medical Center. Dr. Chapin obtained her B.S. in Biology from Boston College, received her MD from the University of Massachusetts and earned her M.A. in Molecular Genetics and Microbiology at the University of Massachusetts. Dr. Chapin is board-certified in Clinical Pathology and holds board certification from the American Board of Medical Microbiology.

Keith Hamilton, MD

Dr. Hamilton received a BA in Chemistry from Franklin And Marshall College and his MD from the University of Pennsylvania School of Medicine. His clinical and research expertise is focused on the treatment of Non-tuberculous mycobacterial infections, Infection Control, Healthcare Epidemiology and Antimicrobial Stewardship.


Kerry LaPlante, Pharm.D., FCCP, FIDSA

Dr. Kerry LaPlante’s Pharm.D. clinical practice site and research program is located at the Veterans Affairs Medical Center in Providence, R.I., and the College of Pharmacy at URI. She is nationally recognized for her work in the treatment, virulence inhibition, control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) and device related infections where she has authored more than 100 peer-reviewed journal articles, abstracts and textbook chapters. Her research program has recently expanded to include an antimicrobial research outcomes component, which focuses on Antimicrobial Stewardship and Comparative Effectiveness and research using the National Veterans Affairs Database databases and statewide initiatives. Dr. LaPlante’s foremost research expertise is in the treatment, outcomes, prevention, virulence inhibition (biofilm and toxin), and decolonization of multiply drug resistant bacteria, specifically Methicillin resistant Staphylococcus aureus (MRSA).

Christine Nyquist MD, MPH/MSPH

Dr. Nyquist is Professor, Pediatrics-Infectious Diseases, Medical Director, Infection Prevention and Control, and Medical Director, Occupational Health. Her scientific interests include immunizations, antimicrobial utilization and resistance, and hospital epidemiology/infection control. She is involved in a wide range of teaching activities. In addition, Dr. Nyquist participates in many local, regional, and national committees related to Pediatric Infectious Diseases and Healthcare Epidemiology.

David Henderson, MD

Dr. David Henderson is deputy director for clinical care and associate director for clinical quality, patient safety, and hospital epidemiology at the NIH Clinical Center. He came to NIH in 1979 as the Clinical Center’s first hospital epidemiologist. After earning his undergraduate degree from Hanover College, Hanover, Indiana and his medical degree from the University of Chicago’s Pritzker School of Medicine, Dr. Henderson completed an internship and residency in internal medicine and a two-year fellowship in infectious diseases at Harbor-UCLA (University of California at Los Angeles) Medical Center. Subsequently, he was appointed assistant professor of medicine at the UCLA School of Medicine. Dr. Henderson’s primary research interests are in the occupational risks for, and prevention of, transmission of bloodborne pathogens, such as hepatitis B, hepatitis C, and HIV, in the healthcare setting, as well as in the epidemiology and prevention of healthcare-associated transmission of multidrug resistant organisms. More recently, Dr. Henderson provided the executive leadership for a team of NIH clinicians and staff in developing and implementing a high-containment clinical unit for the care of patients infected with highly transmissible infections, and, subsequently, in providing care at the NIH Clinical Center for patients who have, or have been exposed to, Ebola Virus Disease.

Erik Dubberke, MD, MSPH

Dr. Dubberke received his BA from Augustana College, and his MD from the University of Illinois at College of Medicine. His clinical expertise is in Infectious diseases, C. difficile infection, fungal infections, infections in transplant patients and infections in cancer patients. His research Interests focus on healthcare epidemiology in transplant and oncology patients, specifically bloodstream infections and C. difficile-associated disease. I study risk factors for these infections and evaluate ways to prevent them. I also am studying risk factors and outcomes of C. difficile-associated disease at Barnes-Jewish Hospital as well as other hospitals that are members of BJC Healthcare. I hope to determine the influence antibiotic prescribing patterns and patient related factors have on the risk of developing C. difficile-associated disease in multiple healthcare settings.